Masimo SpHb has been shown to measure hemoglobin levels with “clinically acceptable accuracy” – even at the lowest levels. This breakthrough technology offers reliable and … Read more
Minovia Therapeutics, a clinical-stage global biotechnology company, is thrilled to announce its attendance at the upcoming Biotech Showcase in San Francisco, CA on Tuesday, January … Read more
Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) held its Annual General Meeting of Shareholders in Vancouver, British Columbia on December 30, 2022, with … Read more
MedMira Inc. (TSXV:MIR) unveiled its financial results for the quarter ending October 31, 2022, revealing a period of strong growth and increased profitability. The Halifax-based … Read more
The submission to regulatory authorities is a crucial step towards obtaining marketing authorization for the use of a new treatment in the fight against unresectable … Read more
Building on the promising results of its monotherapeutic activity in a previous clinical trial, ONC-392 is now entering Phase 2 of a multicenter, open-label combination … Read more
Astex Pharmaceuticals, UK, is proud to congratulate its co-founder, President and CEO, Harren Jhoti, PhD, FRS, FMedSci, on being honoured with an Officer of the … Read more
“Two Years and Older: Negative COVID-19 Test Now Required for Air Travel to Canada!” In response to the surge of COVID-19 cases in the People’s … Read more
Experts have expressed their concerns that the loosening of China’s COVID-19 restrictions could lead to an increased risk of the virus mutating. William Schaffner, professor … Read more
Pfizer Inc. (NYSE: PFE) announced today the positive top-line results from the Phase 3 BENEGENE-2 study (NCT03861273) of its investigational gene therapy, fidanacogene elaparvovec, for … Read more
Evofem Biosciences, Inc. (OTCQB: EVFM) has been granted an extension by the OTC Markets Group to submit its Quarterly Report on Form 10-Q for the … Read more
With extensive experience in the industry, a new director has been appointed to position the company for growth. This individual brings an impressive knowledge base … Read more
Everest Medicines (HKEX: 1952), a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative medicines and vaccines, is proud to announce its new corporate strategy. … Read more
ABM Respiratory Care, a leading medical technology company, is excited to announce the U.S. Food and Drug Administration’s 510(k) clearance of its groundbreaking BiWaze® Clear … Read more
Néovacs has made a significant commitment to increase its funding for the upcoming pivotal Phase III clinical trial of PXT3003, a potential treatment for Charcot-Marie-Tooth … Read more
NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) (“NuGen” or the “Company”) has successfully closed the first tranche of its non-brokered private placement, raising a total of $125,000 … Read more
NXC-201, a pioneering CAR-T therapy for multiple myeloma and AL amyloidosis, will have its latest clinical data unveiled at the upcoming Rotterdam event on February … Read more
Come join us in Rotterdam, Netherlands February 9-11, 2023 for the presentation of updated clinical data on NXC-201, a next-generation CAR-T treatment for multiple myeloma … Read more
The National Cancer Institute recently conducted a Phase 2 clinical trial to assess the efficacy of PDS0101 triple combination in treating HPV16-positive cancer patients who … Read more
Varex Imaging Corporation (Nasdaq: VREX) is thrilled to announce its participation in CJS Securities 23rd Annual New Ideas for the New Year virtual investor conferences, … Read more
CEL-SCI Corporation (NYSE American: CVM) recently announced its financial results for the fiscal year ended September 30, 2022, along with several noteworthy clinical and corporate … Read more
XENOVIEW is a groundbreaking hyperpolarized MRI contrast agent that is the first and only of its kind to receive FDA approval for both adolescents and … Read more
Alphatec Holdings, Inc. (Nasdaq: ATEC) is excited to announce its virtual participation in the 25th Annual Needham Growth Conference! Join us on January 12, 2023 … Read more
Stryker (NYSE: SYK) has announced an upcoming conference call to review the company’s performance for the quarter ending December 31, 2022, and provide an operational … Read more
Akoya Biosciences, Inc. (Nasdaq: AKYA) – The Spatial Biology Company® – is thrilled to announce that it will be taking part in the 41st Annual … Read more
Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) is proud to announce that their Phase 3 trial (NCT05341609) comparing the efficacy and … Read more
Qilu Pharmaceutical is making waves in the medical industry with its innovative bifunctional antibody, QL1706, by presenting the latest progress of its clinical studies at … Read more
Skanska and HGR General Contractors have teamed up to construct a state-of-the-art medical education building for The University of Texas at Tyler. The contract, worth … Read more
Skanska has secured a USD 95M (SEK 960M) contract to expand the Christus Santa Rosa Hospital-Westover Hills Hospital in San Antonio, Texas, USA. The project … Read more
Guardant Health, Inc. (Nasdaq: GH), a cutting-edge precision oncology company, is pleased to announce its attendance at the upcoming 41st Annual J.P. Morgan Healthcare Conference. … Read more
RxSight Inc., a leading ophthalmic medical device company committed to restoring the vision of cataract surgery patients, is thrilled to announce its participation in the … Read more
Cardio Diagnostics Holdings Inc (Nasdaq: CDIO) and Houston Concierge Medicine have joined forces to provide a revolutionary new test for coronary heart disease. Cardio Diagnostics’ … Read more
Harm Reduction Therapeutics (HRT), Inc., the 501(c)(3) nonprofit pharmaceutical company working to prevent opioid overdose deaths, has made an exciting breakthrough: the FDA has accepted … Read more